All News

Results from the phase 3 RATIONALE 302 trial showed tislelizumab-jsgr prolonged survival compared to chemotherapy in patients who received prior systemic treatment.

The accelerated approval of resmetirom, a once-daily, oral thyroid hormone receptor-β agonist, is the first treatment available for patients with this disease.

This finding was evident in both examined groups and regardless of the patients' B-cell maturation antigen-directed therapy status.

Raj Gupta, DC, discusses holistic approaches to managing type 2 diabetes without medication by addressing root causes like diet, toxins, and stress.

The drug is indicated for patients 5 years of age and older with progressive familial intrahepatic cholestasis and cholestatic pruritus in pediatric patients with Alagille syndrome.

Rep. Buddy Carter (R-Ga.) will be giving remarks at its upcoming Congressional Pharmacy Fly-In.

The tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.

At 4 months, 75% of participants achieved remission and no longer showed signs of depression symptoms in a phase 2 clinical trial.

During a time of staff shortages and increasing stress, the need to have an efficient workflow is of vital importance.

Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.

The findings suggest that ruxolitinib cream could aid itch, pain, and sleep disturbance.

Study results indicate early swap to oral antibiotics in Staphylococcus aureus bacteremia is just as effective.

Furthermore, the study authors indicated that patients with lymphoma and community-acquired pneumonia have broader dysregulated responses.

Aspirin, known as acetylsalicylic acid, has been marketed in ways that have de-emphasized potential risks to children.

This treatment improved the severity of symptoms in patients with scalp and nail psoriasis.

Findings originate from phase 3 data that was recently presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting.

The combination of GZ17-6.02 and bortezomib reduced of HDAC, and as a result ATG13 phosphorylation was enhanced, BAK levels increased, and BCL-XL levels were reduced.

A notable revision now includes a dual GIP and GLP-1 receptor agonist (tirzepatide) as an additional option for glycemic management, preferred over insulin.

Case reports have shown a potential association with adverse psychological effects.

Counsel patients about smoking cessation products

This podcast episode discussed the impact of celebrity endorsements on trends in weight loss drugs like Ozempic, body image issues, and the role of pharmacists in educating patients on appropriate use of GLP-1 medications for weight management and chronic diseases.

The findings also indicated that individuals who experienced significant adverse events in childhood were approximately 17% more likely to experience adverse events in adulthood.

The cream significantly reduced abscesses and inflammatory nodules, reaffirming its efficacy as a maintenance option for HS.

Health span, wealth span, advocacy, and ethics are all burgeoning topics within the field of longevity.

Individuals included in the study reported positive changes in fatigue, and disease activity displayed endoscopic and histologic remission.

Tacrolimus is a selective calcineurin inhibitor that exerts inhibitory effects on T-cell proliferation.

Menopause can have severe repercussions on female health which impact quality of life and health span, according to an expert of women’s health.

Although newly approved, there is some debate regarding the benefits and populations in which sotagliflozin will be the most effective.